CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
106 hedge funds and large institutions have $4.25B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 35 reducing their positions, and 23 closing their positions.
Holders
106
Holders Change
–
Holders Change %
0%
% of All Funds
1.68%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
23
Increased
32
Reduced
35
Closed
23
Calls
$7.79M
Puts
$3.61M
Net Calls
+$4.17M
Net Calls Change
-$8.54M
Top Buyers
Top Sellers
| 1 |
RI
1
RTW Investments
New York
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$2.88M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$598K |
| 4 |
4
Alkeon Capital Management
New York
|
$59.4M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$1.29M |
